Will the COVID-19 Pandemic Finally Fuel Drug Repurposing Efforts?
作者信息
Chen Anna, Patel Shivangi, Alcusky Matthew, Maio Vittorio
机构信息
Jefferson College of Population Health, Thomas Jefferson University, Walnut Street, Philadelphia, PA Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA.
出版信息
Am J Med Qual. 2021;36(2):122-124. doi: 10.1097/01.JMQ.0000735440.58551.5b.
Abstract
摘要
相似文献
1
Will the COVID-19 Pandemic Finally Fuel Drug Repurposing Efforts?新冠疫情最终会推动药物再利用的努力吗？
Am J Med Qual. 2021;36(2):122-124. doi: 10.1097/01.JMQ.0000735440.58551.5b.
2
Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic.整合蛋白质组学以促进新兴病毒大流行期间的药物鉴定和再利用。
ACS Infect Dis. 2021 Jun 11;7(6):1303-1316. doi: 10.1021/acsinfecdis.0c00579. Epub 2020 Dec 15.
3
Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19.将季铵化合物重新用作治疗 COVID-19 的潜在药物。
Pharm Res. 2020 May 25;37(6):104. doi: 10.1007/s11095-020-02842-8.
4
In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins.基于计算机的 SARS-CoV-2 主要蛋白酶和刺突蛋白药物再利用。
J Proteome Res. 2020 Nov 6;19(11):4637-4648. doi: 10.1021/acs.jproteome.0c00383. Epub 2020 Sep 21.
5
The COVID-19 Pandemic: An Opportunity to Transform Higher Education in Public Health.新冠疫情：变革公共卫生高等教育的契机。
Public Health Rep. 2021 Jan/Feb;136(1):23-26. doi: 10.1177/0033354920966024. Epub 2020 Oct 27.
6
Drug repurposing in the era of COVID-19: a call for leadership and government investment.新冠疫情时代的药物再利用：呼吁领导力与政府投资。
Med J Aust. 2020 Jun;212(10):450-452.e1. doi: 10.5694/mja2.50603. Epub 2020 May 6.
7
Electronic Health Records for Drug Repurposing: Current Status, Challenges, and Future Directions.电子健康记录在药物再利用中的应用：现状、挑战与未来方向。
Clin Pharmacol Ther. 2020 Apr;107(4):712-714. doi: 10.1002/cpt.1769. Epub 2020 Feb 3.
8
"What Were You Before the War?" Repurposing Psychiatry During the COVID-19 Pandemic.“战前你从事什么工作？”新冠疫情期间精神病学的用途转变
J Clin Psychiatry. 2020 Apr 7;81(3):20com13373. doi: 10.4088/JCP.20com13373.
9
The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.ACE2 受体在 SARS-CoV-2 感染中的必然作用及药物再利用作为 SARS-CoV-2 治疗的合理策略：简明论述。
Curr Mol Med. 2021;21(10):888-913. doi: 10.2174/1573405617666210204212024.
10
Leveraging the Electronic Health Record to Address the COVID-19 Pandemic.利用电子健康记录应对 COVID-19 大流行。
Mayo Clin Proc. 2021 Jun;96(6):1592-1608. doi: 10.1016/j.mayocp.2021.04.008. Epub 2021 Apr 21.
本文引用的文献
1
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
2
A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease.新型抗糖尿病药物治疗非酒精性脂肪性肝病的系统评价。
Ann Pharmacother. 2021 Jan;55(1):65-79. doi: 10.1177/1060028020935105. Epub 2020 Jun 22.
3
Drug repurposing: progress, challenges and recommendations.药物重定位：进展、挑战和建议。
Nat Rev Drug Discov. 2019 Jan;18(1):41-58. doi: 10.1038/nrd.2018.168. Epub 2018 Oct 12.
4
Drug repurposing from the perspective of pharmaceutical companies.从制药公司的角度看药物再利用。
Br J Pharmacol. 2018 Jan;175(2):168-180. doi: 10.1111/bph.13798. Epub 2017 May 18.
5
Drug repositioning: re-investigating existing drugs for new therapeutic indications.药物重新定位：重新研究现有药物以寻找新的治疗适应症。
J Postgrad Med. 2011 Apr-Jun;57(2):153-60. doi: 10.4103/0022-3859.81870.
Zotero 插件